by Jessica Casebolt | Jul 17, 2024 | Providers, Tea Leaves
The Supreme Court’s decision that overturned the longstanding Chevron deference, is expected to trigger a wave of lawsuits across the health care sector. The ruling diminishes federal agencies’ authority to interpret laws and strengthens the...
by Jessica Casebolt | Jul 17, 2024 | Opioid/Substance Use Disorders, Tea Leaves
A KHN article discusses how opioid funds are used across the nation, following a Supreme Court decision impacting settlements with opioid manufacturers. California, set to receive over $4 billion, has begun allocating funds to combat the opioid crisis through various...
by Jessica Casebolt | Jul 17, 2024 | Mental Health, Tea Leaves
Medicare has proposed reimbursing doctors for digital mental health therapies, such as apps and software, marking a significant shift to support treatments that have struggled with adoption due to inconsistent payment and coverage pathways. The Centers for Medicare...
by Jessica Casebolt | Jul 17, 2024 | Health IT, Tea Leaves
The Change Healthcare cyberattack has caused significant upheaval in the U.S. health care system, exposing widespread vulnerabilities that now threaten as many as one in three Americans whose personal information may have been compromised. The breach, which has...
by Jessica Casebolt | Jul 17, 2024 | Providers, Tea Leaves
Telehealth advocates welcomed the Centers for Medicare and Medicaid Services’ (CMS) proposed 2025 Medicare physician fee schedule, which extends key telehealth flexibilities introduced during the COVID-19 pandemic. The proposed rule includes permanent allowances...
by Jessica Casebolt | Jul 17, 2024 | Life Sciences, Tea Leaves
Pfizer has unveiled plans to develop an oral daily medication for weight loss, similar to existing treatments like Ozempic and Zepbound. The pharmaceutical giant reported positive results from clinical trials of its oral GLP-1 agonist candidate danuglipron, indicating...
Recent Comments